Abiopharma

SKYRIZI® (risankizumab) Receives Positive Reimbursement Recommendation by Canada’s Drug Agency for Ulcerative Colitis and AbbVie Concludes Letter of Intent with the pan-Canadian Pharmaceutical Alliance

Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness

GE HealthCare announces CE Mark for the Omni 128cm total body PET/CT system

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunie le 27 novembre 2025

Results of the Votes of the Combined Shareholders’ General Meeting of November 27, 2025

Innate Pharma - Number of Shares and Voting Rights of Innate Pharma as of November 27, 2025

Number of Shares and Voting Rights of Innate Pharma as of November 27, 2025

Medi Lifestyle - Announcement

Eisai Submits New Drug Application for Subcutaneous Formulation of “LEQEMBI®” for the Treatment of Early Alzheimer’s Disease in Japan